Click here for slides on this topic


Dapagliflozin

An oral antihyperglycemic agent of the sodium-glucose co-transporter 2 (SGLT2) inhibitor class.
The following content matched the glossary term: Dapagliflozin

ADA 2015: The 75th Scientific Sessions of the American Diabetes Association

Top

Coverage of data from ADA 2015, June 5-9, 2015 in Boston, Massachusetts

CompanionSetType2DiabetesMedications

Top

Patient education companion set featuring handouts on DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and medications used to treat type 2 diabetes (English and Spanish)

Medications Used To Treat Type 2 Diabetes

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose.

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study

Top

Henry RR, Rosenstock, Edelman S, et al. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2014; Epub ahead of print. DOI: 10.2337/dc13-2955.

Medicamentos para el tratamiento de la diabetes tipo 2

Top

Patient education handout showing medications used to treat type 2 diabetes and where and how these medications work in the body to lower blood glucose—in Spanish.

ADA 2016 Type 2 Diabetes Pharmacologic Therapy

Top

Pharmacologic treatment options for type 2 diabetes from the 2016 ADA guidelines

ADA/European Association for the Study of Diabetes (EASD) Position Statement on Hyperglycemia Management in Type 2 Diabetes

Top

Joint position statement from ADA/EASD with clinical practice recommendations for managing hyperglycemia in type 2 diabetes

Product Indications

Top

Medications used to treat diabetes :: Alpha-glucosidase inhibitors, amylin mimetics, biguanides (metformin), bile acid sequestrants, dopamine receptor agonists, DPP-4 inhibitors, GLP-1 analogs, incretins, insulin, meglitinides, SGLT2 inhibitors, sulphonylureas, thiazolidinediones (TZDs).



Slide Library Results

Search Results for: Dapagliflozin Slides Found: 6
SGLT2 Inhibitors Type 2 Diabetes Treatment Slides | NDEI
SGLT2 Dapagliflozin + Insulin Type 1 Diabetes Treatment Slide | NDEI
Adverse Events Dapagliflozin As Insulin Adjunct in Type 1 Diabetes | NDEI
Dapagliflozin Pharmacokinetics in Type 1 Diabetes SGLT 2 | NDEI
Average Daily Glucose Changes & Insulin Use Dapagliflozin Type 1 Diabetes | NDEI
Dapagliflozin Type 1 Diabetes SGLT2 Data Review | NDEI